Saturn Partners
VC Fund
Boston, United States
Saturn Partners is a VC fund in Boston focused on Finance and Health Care. Since 1994, Saturn Partners has taken an active role in the formation and management of seed and early-stage technology companies. Saturn looks for companies with potential for significant growth, primarily in information and financial technology, but also in advanced materials and specialty energy.We enjoy the challenge of rolling up oursleeves and teaming with creative entrepreneurs to build great companies. We’re not the type of investors to just take part in the board call each quarter. When you need us, we’ll be there with the capital and operational expertise necessary to unleash your company’s potential. Initial investments typically range from $1 million to $3 million, with reserve amounts varying based on each company’s expected future needs.
- Total investments:
- 25
- Last investment:
- Lead investor:
- 28%
- Fund size:
- $1.5M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Saturn Partners invests in
Stages Saturn Partners invests in
Countries Saturn Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1M–$3.7M
- Series A
- $4M–$350M
Investment Focus
Industry
- Finance 3 (12%)
- Health Care 3 (12%)
- Biotechnology 3 (12%)
- FinTech 2 (8%)
- Software 2 (8%)
Stage
- Funding Round 6 (24%)
- Seed 5 (20%)
- Series A 5 (20%)
- Series B 2 (8%)
- Series C 2 (8%)
Country
- United States 16 (64%)
- United Kingdom 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ed Lafferty
General Partner & CFO
|
General Partner & CFO | Total investments: 0 | Find email | |
Jeffrey McCormick
Founder, Managing Partner
|
Founder, Managing Partner | Total investments: 1 | Find email | |
William Guttman
General Partner
|
General Partner | Total investments: 28 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication ofimproving lung function and is found in several asthma-related treatments. | $75M / Series A / Feb 13, 2024 | ||
| Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication ofimproving lung function and is found in several asthma-related treatments. | $350M / Series A / Jul 12, 2022 | ||
| The Third Pole™ core technology is an innovative clean, tankless inhaled Nitric Oxide (NO) proven equivalent to marketed tank-gas in the lab. Nitric oxide saves hypoxic newborns, but is available only in a limited number of countries, for those who can afford it, by physicians who have access to the product. We intend to make NO availableworldwide. | Dec 28, 2017 | ||
| Willow Wealth enables you to build a complete private markets portfolio across real estate, private credit, private equity, and more. Our platform provides access to differentiated individual investments and diversified funds, as well as an automated investing solution that handles everything for you. No matter your goals, our platform aims to makeprivate markets investing simple and accessible. Join more than 500,000 members and start investing in private markets today at willowwealth.com. | Seed / Sep 30, 2016 | ||
| Trunomi’s rules-based platform is the leader in Enterprise Data Privacy Compliance. Enabling businesses for the first time to understand what data they hold, under what regulation and why. Allowing companies to comply with current and future global regulations from a single platform.Trunomi never sees or stores your customer’s personal data dueto its patented technology; and for this reason, Trunomi’s technology is not bound by jurisdictional borders surrounding personal data.Certified to operate to NSA security standards and validated by Baker McKenzie, Trunomi is a zero-risk solution allowing businesses to: • Prove Compliance with all Global Regulations - now and forever • Visualise your customer data from a single screen • Map your customer data • Automate Data Subject Request (DSR) management • Turn Privacy into a customer experience • Switch on Privacy easily, with a developer-first approach | $3M / Seed / May 19, 2016 | ||
| Willow Wealth enables you to build a complete private markets portfolio across real estate, private credit, private equity, and more. Our platform provides access to differentiated individual investments and diversified funds, as well as an automated investing solution that handles everything for you. No matter your goals, our platform aims to makeprivate markets investing simple and accessible. Join more than 500,000 members and start investing in private markets today at willowwealth.com. | $3.7M / Seed / May 04, 2016 | ||
| Kaleo Software California-based company that automates self-help across the enterprise knowledge in question and answer format. The company drives self-help adoption by automatically providing bite-sized answers to trending questions. It captures and tags information to create an organically growing knowledge base. Users can find information basedon input from co-workers and topic experts. Powerful analytics enable users to see what topics are trending and find experts to assist them.Kaleo Software connects employees with subject matter expertise from their organization's internal experts and from within any technology platform anytime, anywhere. The company also integrates into popular business applications like SharePoint, ServiceNow, and Slack to deliver information when and where employees need it.Founded in 2012 and is headquartered in El Segundo, CA, USA. | $7M / Series A / Oct 20, 2015 | ||
| With more than 6 million members, and millions of connections across more than 30,000 local communities, Alignable is the online network where small business owners across North America drive leads and prospects, generate referrals, land new business, build trusted relationships, and share great advice.Members use Alignable to get the industryanswers they need, connect within their local business community or across the country, and increase buzz for their business.Headquartered in Boston, Alignable officially launched its services in 2014. It's venture-backed by Mayfield Fund, Recruit Strategic Partners, Saturn Partners, NextView Ventures and Lead Edge Capital. | $8M / Sep 21, 2015 | ||
| Trunomi’s rules-based platform is the leader in Enterprise Data Privacy Compliance. Enabling businesses for the first time to understand what data they hold, under what regulation and why. Allowing companies to comply with current and future global regulations from a single platform.Trunomi never sees or stores your customer’s personal data dueto its patented technology; and for this reason, Trunomi’s technology is not bound by jurisdictional borders surrounding personal data.Certified to operate to NSA security standards and validated by Baker McKenzie, Trunomi is a zero-risk solution allowing businesses to: • Prove Compliance with all Global Regulations - now and forever • Visualise your customer data from a single screen • Map your customer data • Automate Data Subject Request (DSR) management • Turn Privacy into a customer experience • Switch on Privacy easily, with a developer-first approach | $2.5M / Seed / Sep 03, 2015 | ||
| Omaze provides an online fundraising platform. It gives everyone a chance to win once-in-a-lifetime opportunities, like a trip to SpaceX's Singularity University headquarters, or a hang-out session with the cast of It's Always Sunny In Philadelphia. | $9M / Series A / Jul 15, 2015 | ||
| See all 25 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Saturn Partners invest in?
Saturn Partners invests primarily in Finance, Health Care and Biotechnology startups, most often at Funding Round and Seed stage. Most of the 25 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Saturn Partners's check size?
Saturn Partners typically joins rounds of $1M–$3.7M at Seed and $4M–$350M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Saturn Partners participates in.
How do I contact Saturn Partners?
Public channels for Saturn Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Saturn Partners?
The team at Saturn Partners includes Ed Lafferty (General Partner & CFO), Jeffrey McCormick (Founder, Managing Partner) and William Guttman (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
